950502-86-0

Upstream product

• 4513-73-9 2-(4-methoxy-3-methylphenyl)acetic acid 

Downstream Products

• 950502-88-2 (3-{[2-(2-fluoro-phenyl)-ethylamino]-methyl}-4-methoxy-phenyl)-acetic acid methyl ester 
• 950502-90-6 [2-(2-fluoro-phenyl)-ethyl]-[5-(2-hydroxy-ethyl)-2-methoxy-benzyl]-carbamic acid tert-butyl ester 
• 950502-89-3 [3-({tert-butoxycarbonyl-[2-(2-fluoro-phenyl)-ethyl]-amino}-methyl)-4-methoxy-phenyl]-acetic acid methyl ester 
• 1158804-91-1 methyl 2-(3-(bromomethyl)-4-methoxyphenyl)acetate 
• 950502-87-1 (3-formyl-4-methoxy-phenyl)-acetic acid 

Relevant academic research and scientific papers

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA, COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, BACTERIAL INFECTIONS AND DERMATOSIS

The present invention provides compounds of formula (I) wherein R 1, R2, R3 and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

BEZOTHIAZOL DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS

The present invention relates to compounds according to formula (I) , a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.